Evidence map›Paper›PMID 33533720›Full record

ArticleJMIR formative research2021

Administering Virtual Reality Therapy to Manage Behavioral and Psychological Symptoms in Patients With Dementia Admitted to an Acute Care Hospital: Results of a Pilot Study.

Lora Appel, Erika Kisonas, Eva Appel, Jennifer Klein, Deanna Bartlett, Jarred Rosenberg, Christopher Nc Smith

3 registry-linked trialsOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JMIR formative research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04988360 nacompletednot on this mapstarted 2022, after this paper: background citation

VRx@Home: Pilot RCT to Evaluate the Effectiveness of Immersive Virtual Reality Therapy on People With Dementia Living at Home

TypeinterventionalSponsorUniversity Health Network, TorontoRan2022 to 2022Enrolled7ConditionsDementiaArmsHMD: Immersive VR, Tablet: Non-immersive VR
NCT05265182 nacompletednot on this mapstarted 2022, after this paper: background citation

Developing an Immersive Gamification Technology System (ImGTS) for the Management of Patients With Behavioral and Psychological Symptoms of Dementia (Phase 1 Trial)

TypeinterventionalSponsorAugmented eXperience E-health LaboratoryRan2022 to 2022Enrolled30ConditionsDementia AlzheimersArmsvirtual reality
NCT05867641 narecruitingnot on this mapstarted 2025, after this paper: background citation

VR&R: Providing Respite to Caregivers by Managing BPSDs and Improving QoL in People with Dementia Using Immersive VR-Therapy

TypeinterventionalSponsorUniversity Health Network, TorontoRan2025 to 2027Enrolled50ConditionsDementiaArmsImmersive VR Therapy in Head-Mounted Display (HMD) (Solo), Immersive VR Therapy in a Head-Mounted Display (HMD) (Social)
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lora AppelFaculty of Health, School of Health Policy and Management, York University, Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-7176-7191
Erika KisonasOpenLab, University Health Network, Toronto, ON, Canada.ORCID https://orcid.org/0000-0001-7806-2285
Eva AppelOpenLab, University Health Network, Toronto, ON, Canada.ORCID https://orcid.org/0000-0001-7112-3022
Jennifer KleinFaculty of Health, School of Health Policy and Management, York University, Toronto, ON, Canada.ORCID https://orcid.org/0000-0001-7424-9982
Deanna BartlettFaculty of Health, School of Health Policy and Management, York University, Toronto, ON, Canada.ORCID https://orcid.org/0000-0001-6474-068X
Jarred RosenbergMichael Garron Hospital, Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-8716-0079
Christopher Nc SmithMichael Garron Hospital, Toronto, ON, Canada.ORCID https://orcid.org/0000-0002-3277-3388
University Health Network · CAToronto East General Hospital · CAYork University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs virtual reality (VR) technologies become increasingly accessible and affordable, clinicians are eager to try VR therapy as a novel means to manage behavioral and psychological symptoms of dementia, which are exacerbated during acute care hospitalization, with the goal of reducing the use of antipsychotics, sedatives, and physical restraints associated with negative adverse effects, increased length of stay, and caregiver burden. To date, no evaluations of immersive VR therapy have been reported for patients with dementia in acute care hospitals.

objectiveThis study aimed to determine the feasibility (acceptance, comfort, and safety) of using immersive VR therapy for people living with dementia (mild, moderate, and advanced) during acute care hospitalization and explore its potential to manage behavioral and psychological symptoms of dementia.

methodsA prospective, longitudinal pilot study was conducted at a community teaching hospital in Toronto. The study was nonrandomized and unblinded. A total of 10 patients aged >65 years (mean 86.5, SD 5.7) diagnosed with dementia participated in one or more research coordinator-facilitated sessions of viewing immersive 360° VR footage of nature scenes displayed on a Samsung Gear VR head-mounted display. This mixed-methods study included review of patient charts, standardized observations during the intervention, and pre- and postintervention semistructured interviews about the VR experience.

resultsAll recruited participants (N=10) completed the study. Of the 10 participants, 7 (70%) displayed enjoyment or relaxation during the VR session, which averaged 6 minutes per view, and 1 (10%) experienced dizziness. No interference between the VR equipment and hearing aids or medical devices was reported.

conclusionsIt is feasible to expose older people with dementia of various degrees admitted to an acute care hospital to immersive VR therapy. VR therapy was found to be acceptable to and comfortable by most participants. This pilot study provides the basis for conducting the first randomized controlled trial to evaluate the impact of VR therapy on managing behavioral and psychological symptoms of dementia in acute care hospitals.

Indexed as

agedbehavioral symptomsdementiahospitalizationhospitals, communityhospitals, generalhumansmobile phonenaturesensory art therapiesvirtual realitywearable electronic devices

Identifiers

PMID33533720
PMCPMC7889418
OpenAlexW3111390426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.